← Holders
Birchview Capital, LP
What Birchview Capital, LP reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1618205 · Filed Nov 13, 2026
- Positions
- 79
- Reported value
- $173.1M
- Opened
- 23
- Closed
- 17
- Other managers included
- 0
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$132.4M69 positions
- Dec 31, 2025$170.8M68 positions
- Mar 31, 2026$175.7M73 positions
- Jun 30, 2026$213.8M73 positions
- Sep 30, 2026$173.1M79 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
KLACKLA Corp | 166.9K | −6.5% | $32.5M | 18.8% |
BMYBristol Myers Squibb Co | 224.2K | −24.6% | $14M | 8.1% |
LRCXLAM Research Corp | 30K | −14.3% | $9.9M | 5.7% |
BIODESIX INCCOM | 286.8K | ±0% | $8.6M | 4.9% |
CORTCorcept Therapeutics Inc | 55.2K | −3.5% | $6.4M | 3.7% |
OVVOvintiv Inc. | 107.5K | ±0% | $6.2M | 3.6% |
RAREUltragenyx Pharmaceutical Inc. | 373.7K | New | $5.6M | 3.2% |
SLDBSolid Biosciences Inc. | 716K | +7.5% | $5.2M | 3% |
PTGXProtagonist Therapeutics, Inc | 35K | −0.1% | $4.9M | 2.8% |
PRTAProthena Corp Public Ltd Co | 449K | ±0% | $3.8M | 2.2% |
HALOHalozyme Therapeutics, Inc. | 33.4K | +0.3% | $3.7M | 2.1% |
STOKStoke Therapeutics, Inc. | 138K | −22.5% | $3.6M | 2.1% |
NBIXNeurocrine Biosciences Inc | 25.2K | −7.4% | $3.6M | 2.1% |
ACADAcadia Pharmaceuticals Inc | 171K | ±0% | $3.4M | 2% |
NTLAIntellia Therapeutics, Inc. | 281.4K | −27.0% | $3.4M | 2% |
NKTRNektar Therapeutics | 46K | −43.2% | $2.8M | 1.6% |
VIRVir Biotechnology, Inc. | 227K | +3.2% | $2.5M | 1.5% |
ZBIOZenas BioPharma, Inc. | 93.4K | −0.2% | $2.5M | 1.5% |
CONTINEUM THERAPEUTICS INC (CTNM) P @ 15.0 01/15/2027PUT | 3.5K | New | $2.3M | 1.3% |
ABVXAbivax S.A. | 21K | +23.5% | $2.1M | 1.2% |
BIIBBiogen Inc. | 9K | ±0% | $2M | 1.2% |
ALKSAlkermes plc. | 50K | ±0% | $2M | 1.2% |
DFTXDefinium Therapeutics, Inc. | 52K | +160.0% | $2M | 1.1% |
CYTKCytokinetics Inc | 30K | ±0% | $2M | 1.1% |
CLDXCelldex Therapeutics, Inc. | 57.2K | −18.2% | $1.9M | 1.1% |
EQTEQT Corp | 34.6K | ±0% | $1.7M | 1% |
CMPXCompass Therapeutics, Inc. | 1.6M | −6.0% | $1.6M | 0.9% |
XENEXenon Pharmaceuticals Inc. | 43K | +104.4% | $1.6M | 0.9% |
RLMDRelmada Therapeutics, Inc. | 408.1K | ±0% | $1.5M | 0.9% |
TVTXTravere Therapeutics, Inc. | 25K | −13.8% | $1.5M | 0.9% |
ADAGAdagene Inc. | 430K | +79.2% | $1.4M | 0.8% |
UTHRUnited Therapeutics Corp | 2.5K | −44.5% | $1.4M | 0.8% |
FCXFreeport-McMoran Inc | 18K | −0.0% | $1.3M | 0.7% |
IRLAIRulya Therapeutics Inc. | 40.6K | New | $1.3M | 0.7% |
VALNValneva SE | 201.4K | New | $1.2M | 0.7% |
BBIOBridgeBio Pharma, Inc. | 18.7K | +114.4% | $1.2M | 0.7% |
IMNMImmunome Inc. | 55.6K | +11.2% | $1.2M | 0.7% |
AXSMAxsome Therapeutics, Inc. | 6K | ±0% | $1.1M | 0.6% |
ANNEXON INC (ANNX) P @ 5.0 01/15/2027PUT | 4.4K | New | $1M | 0.6% |
JATTJATT II Acquisition Corp. | 90.5K | New | $1M | 0.6% |
FHTXFoghorn Therapeutics Inc. | 282.3K | +0.1% | $1M | 0.6% |
PHVSPharvaris N.V. | 29.8K | ±0% | $946.7K | 0.5% |
QUIDELORTHO CORPCOM | 89.4K | ±0% | $942K | 0.5% |
BLSMBlossomHill Therapeutics, Inc. | 50K | New | $932K | 0.5% |
DISC MEDICINE INC (IRON) P @ 80.0 01/15/2027PUT | 450 | New | $841.5K | 0.5% |
CSTLCastle Biosciences Inc | 22.9K | +76.6% | $814.9K | 0.5% |
DRUGBright Minds Biosciences Inc. | 15.4K | New | $767.2K | 0.4% |
HROWHarrow, Inc. | 24K | ±0% | $739.2K | 0.4% |
BCYCBicycle Therapeutics PLC | 176.4K | −43.7% | $649.3K | 0.4% |
VYGRVoyager Therapeutics, Inc. | 224.9K | +199.3% | $602.8K | 0.3% |
SLGLSol-Gel Technologies Ltd. | 7.6K | New | $564.5K | 0.3% |
OLMAOlema Oncology, Inc. | 59K | −70.4% | $509.8K | 0.3% |
CRMDCorMedix Inc. | 65.9K | New | $507.2K | 0.3% |
CAMPCamp4 Therapeutics Corp | 120K | ±0% | $484.8K | 0.3% |
ABEOAbeona Therapeutics Inc. | 90.7K | New | $476.2K | 0.3% |
ALTAltimmune, Inc. | 161K | +5.4% | $460.4K | 0.3% |
VORVor Biopharma Inc. | 24K | New | $457.9K | 0.3% |
MLTXMoonLake Immunotherapeutics | 36.2K | New | $423.8K | 0.2% |
AEMDAethlon Medical Inc | 62.8K | New | $409.7K | 0.2% |
LUNGPulmonx Corp | 200K | −0.3% | $382K | 0.2% |
PACBPacific Biosciences of California, Inc. | 160K | −88.1% | $379.2K | 0.2% |
TRINTrinity Capital Inc. | 20K | ±0% | $351K | 0.2% |
SLNSilence Therapeutics plc | 30K | −57.9% | $327.9K | 0.2% |
CGEMCullinan Therapeutics, Inc. | 20K | ±0% | $307K | 0.2% |
KBDCKayne Anderson BDC, Inc. | 20K | ±0% | $251.2K | 0.1% |
RZLTRezolute, Inc. | 60.3K | New | $249.6K | 0.1% |
TRDAEntrada Therapeutics, Inc. | 36.8K | New | $234K | 0.1% |
IMUXImmunic, Inc. | 21.9K | New | $203.8K | 0.1% |
CRDLCardiol Therapeutics Inc. | 100K | New | $166K | 0.1% |
OCULOcular Therapeutix, Inc | 20.5K | −1.0% | $156.9K | 0.1% |
KAZIA THERAPEUTICS LTDSPONSORED ADS | 16K | New | $153.5K | 0.1% |
KYNBKyntra Bio, Inc. | 22.6K | ±0% | $150.1K | 0.1% |
ELUTElutia Inc. | 165.1K | ±0% | $130.4K | 0.1% |
BMEABiomea Fusion, Inc. | 93.5K | New | $124.4K | 0.1% |
GUTSFractyl Health, Inc. | 165.5K | New | $90.1K | 0.1% |
IVVDInvivyd, Inc. | 76K | −77.8% | $66.1K | 0.1% |
LPCNLipocine Inc. | 16.7K | ±0% | $36.8K | 0.1% |
DCGODocGo Inc. | 39.1K | ±0% | $15.6K | 0.1% |
BRISTOL MYERS SQUIBB CO RTSRIGHT 12/30/2030 | 98.5K | New | $12.3K | 0.1% |